101 related articles for article (PubMed ID: 12324566)
1. Oophorectomy in carriers of BRCA mutations.
Zhuang SH; Leonard GD; Swain SM
N Engl J Med; 2002 Sep; 347(13):1037-40; author reply 1037-40. PubMed ID: 12324566
[No Abstract] [Full Text] [Related]
2. Oophorectomy in carriers of BRCA mutations.
Whitfield GA
N Engl J Med; 2002 Sep; 347(13):1037-40; author reply 1037-40. PubMed ID: 12353513
[No Abstract] [Full Text] [Related]
3. Prophylactic oophorectomy to reduce the risk of ovarian and breast cancer in carriers of BRCA mutations.
Haber D
N Engl J Med; 2002 May; 346(21):1660-2. PubMed ID: 12024000
[No Abstract] [Full Text] [Related]
4. Risk-reducing salpingo-oophorectomy for BRCA mutation carriers.
Haldar K; Crawford R
Maturitas; 2010 Nov; 67(3):290. PubMed ID: 20869823
[No Abstract] [Full Text] [Related]
5. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
Kauff ND; Satagopan JM; Robson ME; Scheuer L; Hensley M; Hudis CA; Ellis NA; Boyd J; Borgen PI; Barakat RR; Norton L; Castiel M; Nafa K; Offit K
N Engl J Med; 2002 May; 346(21):1609-15. PubMed ID: 12023992
[TBL] [Abstract][Full Text] [Related]
6. Oral contraceptives, salpingo-oophorectomy and hormone replacement therapy in BRCA1-2 mutation carriers.
Biglia N; Mariani L; Ponzone R; Sismondi P
Maturitas; 2008 Jun; 60(2):71-7. PubMed ID: 18472232
[No Abstract] [Full Text] [Related]
7. Association of risk-reducing surgery with cancer risks and mortality in BRCA mutation carriers.
Heemskerk-Gerritsen BA; Kriege M; Seynaeve C
JAMA; 2010 Dec; 304(24):2695; author reply 2695-6. PubMed ID: 21177502
[No Abstract] [Full Text] [Related]
8. Oophorectomy in carriers of BRCA mutations.
Peshkin BN; DeMarco TA; Schwartz MD
N Engl J Med; 2002 Sep; 347(13):1037-40; author reply 1037-40. PubMed ID: 12353511
[No Abstract] [Full Text] [Related]
9. Oophorectomy in carriers of BRCA mutations.
Anderson WF; Brawley OW; Chang S
N Engl J Med; 2002 Sep; 347(13):1037-40; author reply 1037-40. PubMed ID: 12353512
[No Abstract] [Full Text] [Related]
10. Surveillance of survivors: follow-up after risk-reducing salpingo-oophorectomy in BRCA 1/2 mutation carriers.
Chapman JS; Powell CB; McLennan J; Crawford B; Mak J; Stewart N; Chen LM
Gynecol Oncol; 2011 Aug; 122(2):339-43. PubMed ID: 21531449
[TBL] [Abstract][Full Text] [Related]
11. [Preventive oophorectomy in women exhibiting BRCA mutations].
Roseau E
Presse Med; 2003 Feb; 32(4):149-50. PubMed ID: 12613483
[No Abstract] [Full Text] [Related]
12. CA125 screening after risk-reducing salpingo-oophorectomy: are the titers too high, or is it all just too much?
Bradford LS; Schorge JO
Menopause; 2011 Feb; 18(2):123-4. PubMed ID: 21191312
[No Abstract] [Full Text] [Related]
13. Prophylactic salpingo-oophorectomy in a series of 89 women carrying a BRCA1 or a BRCA2 mutation.
Mahajan NN
Cancer; 2007 Dec; 110(12):2819; author reply 2819-20. PubMed ID: 17969078
[No Abstract] [Full Text] [Related]
14. What have we learned from risk-reducing salpingo-oophorectomy?
Greene MH; Mai PL
J Natl Cancer Inst; 2009 Jan; 101(2):70-1. PubMed ID: 19141782
[No Abstract] [Full Text] [Related]
15. Short-term surgical outcome and safety of risk reducing salpingo-oophorectomy in BRCA1/2 mutation carriers.
Kenkhuis MJ; de Bock GH; Elferink PO; Arts HJ; Oosterwijk JC; Jansen L; Mourits MJ
Maturitas; 2010 Jul; 66(3):310-4. PubMed ID: 20409655
[TBL] [Abstract][Full Text] [Related]
16. Choice of management of southern Chinese BRCA mutation carriers.
Kwong A; Wong CH; Shea C; Suen DT; Choi CL
World J Surg; 2010 Jul; 34(7):1416-26. PubMed ID: 20182723
[TBL] [Abstract][Full Text] [Related]
17. Unraveling the next chapter: sexual development, body image, and sexual functioning in female BRCA carriers.
Matloff ET; Barnett RE; Bober SL
Cancer J; 2009; 15(1):15-8. PubMed ID: 19197168
[TBL] [Abstract][Full Text] [Related]
18. Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers.
Rhiem K; Foth D; Wappenschmidt B; Gevensleben H; Büttner R; Ulrich U; Schmutzler RK
Arch Gynecol Obstet; 2011 Mar; 283(3):623-7. PubMed ID: 20428881
[TBL] [Abstract][Full Text] [Related]
19. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
20. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ
Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]